epistaxis

Reply to “An Approach to Manage Epistaxis in the COVID-19 Pandemic in Resource-Constrained Settings”

There is a growing interest on the risk of health care pro- fessionals to be exposed to SARS-CoV-2 during their activ- ity. Recent studies have demonstrated that SARS-CoV-2 can be easily transmitted by symptomatic and asymptomatic carriers, contributing to viral diffusion and pandemic potential. Moreover, studies have reported that SARS-CoV-2 maintains its biologic stability in aerosol and on surfaces for hours to days

Clinical recommendations for epistaxis management during the COVID-19 pandemic

Epistaxis is a common complaint in the general population, and its treatment is a common procedure in emergency departments. In the COVID-19 era, procedures involving airway management are a particular risk for health care workers due to the high virulence of the virus, the transmission through aerosol, and the risk of contagion from asymptomatic patients. In this article, we propose a simple memorandum of clinical recommendations to minimize the risk of operator infection deriving from epistaxis management.

Septal Nasal Extramedullary Plasmacytoma: A Rare Tumor in an Unusual Area

We present an extreme rare case of extramedullary nasal plasmacitoma that arise from nasal septum. The mass surgically removed was analyzed by a pathologist who diagnosed an extramedullary nasal plasmacytoma. The patient did not present systemic involvement. A short cycle of radiotherapy was performed after the surgery. At 9-month follow-up, the patient is recurrence free.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma